Biocon may move to Rs 823: AnandRathi

Biocon has reported a growth of 21.2 percent in its consolidated revenues at Rs 1,123 cr in Q1-FY19 as against Rs 927 cr in Q1-FY18.

Moneycontrol News

October 08, 2018 / 11:44 IST

Aurobindo Pharma Ltd.

26 Aug, 2025 12:21

Volume

Todays L/H

AnandRathi

Biocon, is one the largest and fully-integrated, innovation-led bio pharmaceutical company emerging globally bio pharmaceutical enterprise serving customers in over 120 countries.

Biocon has reported a growth of 21.2 percent in its consolidated revenues at Rs 1,123 cr in Q1-FY19 as against Rs 927 cr in Q1-FY18.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol are their own, and not that of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

Moneycontrol News

first published: Oct 8, 2018 11:44 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347